June 27, 2017 — Today, the U.S. Food and Drug Administration is taking two new, important steps to increase competition in the market for prescription drugs and facilitate entry of lower-cost alternatives. The agency published a list of off-patent,…Original Article
You may also like
Aesthetic Surgical Rep Austin/San Antonio- Allergan...
Territory Sales Representative
Biopsy Sales Specialist – Miami, FL
Clinical Specialist
Medical Device Sales – Modesto, CA
Associate Territory Manager, Neurovascular –...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.